ARS Investment Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-8,785
Closed -$1.17M – 126
2018
Q1
$1.17M Buy
8,785
+608
+7% +$81.7K 0.14% 99
2017
Q4
$1.22M Sell
8,177
-135
-2% -$18.4K 0.15% 102
2017
Q3
$1.1M Buy
8,312
+795
+11% +$107K 0.14% 102
2017
Q2
$1M Buy
7,517
+75
+1% +$10.1K 0.14% 106
2017
Q1
$1M Buy
7,442
+462
+7% +$59.8K 0.15% 102
2016
Q4
$838K Buy
+6,980
New +$823K 0.13% 108

Other funds holding CLX

ARS Investment Partners's CLX Position: Q2 2018 in Review

ARS Investment Partners sold out of Clorox (CLX) in Q2 2018, closing a stake of 8,785 shares — an estimated $1.17M sold.

ARS Investment Partners first reported a position in CLX in Q4 2016 and held it in 6 quarters. The position peaked at $1.22M in Q4 2017. 917 funds tracked by Wall St. Rank hold CLX as of Q2 2018.

  • ARS Investment Partners reported no remaining Clorox position as of Q2 2018 after selling out during the quarter.
  • ARS Investment Partners sold 8,785 Clorox shares in Q2 2018, an estimated $1.17M.
  • ARS Investment Partners first reported a position in Clorox in Q4 2016 and held it in 6 quarters.
  • ARS Investment Partners's Clorox position peaked at $1.22M in Q4 2017.
  • 917 funds tracked by Wall St. Rank held Clorox as of Q2 2018.

Based on ARS Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.